Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Full Press Release Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)